Evolus Inc. Files 2024 Executive Compensation Details
Ticker: EOLS · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1570562
Sentiment: neutral
Topics: executive-compensation, governance, annual-report
Related Tickers: EVLS
TL;DR
Evolus exec comp details out for 2024. Equity awards and valuations disclosed.
AI Summary
Evolus, Inc. filed its DEF 14A on April 25, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted, outstanding, and changes in their fair value for key personnel, reflecting the company's compensation structure and performance incentives.
Why It Matters
This filing provides insight into how Evolus, Inc. compensates its top executives, which can influence employee morale, retention, and the company's overall financial strategy.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the details on executive compensation can sometimes reveal potential governance issues or significant changes in executive incentives that may impact future performance.
Key Players & Entities
- Evolus, Inc. (company) — Filer of the DEF 14A
- 0001570562-25-000066 (filing_id) — Accession Number for the filing
- 20250425 (date) — Filing Date
- 20241231 (date) — Fiscal Year End
FAQ
What is the primary purpose of this DEF 14A filing for Evolus, Inc.?
The primary purpose of this DEF 14A filing is to provide detailed information regarding the company's executive compensation, director compensation, and corporate governance practices for the fiscal year ending December 31, 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 25, 2025.
What fiscal year does the compensation information in this filing primarily cover?
The compensation information in this filing primarily covers the fiscal year ending December 31, 2024.
What is Evolus, Inc.'s Standard Industrial Classification (SIC) code?
Evolus, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Evolus, Inc. headquartered?
Evolus, Inc. is headquartered in Newport Beach, California, with its business address listed as 520 Newport Center Drive, Suite 1200, Newport Beach, CA 92660.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Evolus, Inc. (EOLS).